Skip to content
  • HOME
  • SUBSCRIPTIONS
  • EVENTS
  • WEBINARS
  • EVENTS ON DEMAND
  • START TRIAL
  • ABOUT GROWTH CAPITALIST
  •
  • Growth Capitalist
  • Growth Capitalist
  • PREMIUM
  • NEWS
  • MARKETS
  • LEGAL
  • EXECUTIVE MOVES
  • VIEWS
  • ALPHABASE
  • Global Navigation
    • HOME
    • SUBSCRIPTIONS
    • EVENTS
    • WEBINARS
    • EVENTS ON DEMAND
    • START TRIAL
    • ABOUT GROWTH CAPITALIST

Growth Capitalist News and Analysis of Emerging Growth Company Finance

Growth Capitalist (https://growthcapitalist.com/tag/biotech/page/34/)

  • PREMIUM
  • NEWS
  • MARKETS
  • LEGAL
  • EXECUTIVE MOVES
  • VIEWS
  • ALPHABASE
Subscribe

Biotech

Deals

Nemus Bioscience Raises $5M at 21% Discount via Midtown Partners & Co.

By Staff | August 21, 2015

Nemus Bioscience (OTC:NMUS) announced that it has raised $5,000,000 in a Convertible Preferred Stock transaction.

Deals

UNIQURE N.V. Raises $38M at 20% Premium From Bristol-Myers Squibb

By Staff | August 10, 2015

UNIQURE N.V. (NASDAQ GS:QURE) announced that it has raised $38,571,000 in a Common Stock transaction.

Deals

Peregrine Pharmaceuticals Secures $50M ATM via MLV & Co.

By Staff | August 10, 2015

Peregrine Pharmaceuticals (NASDAQ CM:PPHM) announced that it has secured up to $50,000,000 in an ATM (At the Market) transaction.

Deals

Marina Biotech Raises $1M at 9% Discount

By Staff | August 7, 2015

Marina Biotech (OTC:MRNA) announced that it has raised $1,100,000 in a Convertible Preferred Stock transaction.

Load more posts

Subscriber Login



signup now | forgot password?

Growth Capital Investor

  • April 26, 2016 Issue
  • Past Issues
  • Next issue: August 23, 2016

Reg A Report

  • Featured in Category
    FAT Brands Starts Strong on Nasdaq

    On a side street off Times Square brokers and traders lined up earlier this week for a rare treat outside of Nasdaq’s Manhattan market center: free Fatburgers. Mark Elenowitz, the investment banker behind the $24 million Regulation A capital raise of FAT Brands, was glowing with pride. FAT Brands opening IPO day was here and market interest had driven the stock to open above the $12 Reg A offer price. The first trade sold at $12.80 and the stock soared to $13.99 in the morning hours. Elenowitz and his team at Tripoint Global Equities had worked all weekend to ensure the 2 million shares sold cleared the DTC (Depository Trust Company) and the hundreds of retail investors who bought stock through Tripoint’s online crowdfunding portal, BANQ, had their shares in their retail accounts available to trade immediately. FAT Brands is controlled by Andy Wiederhorn, head of the investment firm Fog Cutter Capital Group. The Southern California burger joint Fatburger, often touted by Hollywood celebrities, was started by Lovie Yancey and Charles Simpson. Yancey first opened a three-seater burger stand in the late 1940s in front of her house in South Central Los Angeles. FAT Brands, which stands for Fresh-Authentic-Tasty, owns multiple franchise chains focused on American food served in a fast casual setting. Fatburger is a 65-year-old company fashioned as a self-serve burger joint that competes with In-n-Out and Shake Shack (SHAK). Buffalo’s Café was founded in Roswell, Ga. in 1985, and is known for its chicken wings with 13 different sauces. And the company’s newest acquisition, Ponderosa and Bonanza Steakhouse, is a chain started in 1963 by Dan Blocker, who was known for his role as Hoss Cartwright in the TV western series Bonanza. CLICK HEADLINE FOR MORE>>

  • Consumer Services
    FAT Brands
    FAT Brands Readies Close of $24M APO

    Fast-casual dining franchise company FAT Brands expects to close it’s $24 million Reg A offering as soon as Oct. 20, according to company insiders. The quick closing follows reports that the company attracted millions of committed capital on its first day after the Securities and Exchange Commission qualified the offering on October 3. The owner of Fatburger and Buffalo’s Café is selling two million shares at $12, with a minimum investment of $500, from institutional and retail investors. The deal is being sold by Tripoint Global Securities as the exclusive bookrunner.

  • Featured
    Zacks Small Cap Research Head and Banker Charged with Insider Trading

    The broker-dealer division of Chicago-based Zacks Investment Research, has been charged by the Securities and Exchange Commission for failure to supervise staff who traded on non-public material information. The action is a blow to the nascent Reg A research market, where Zacks has been the first and only traditional sell-side broker to offer equity research on Reg A issuers.

Growth Capitalist publishes news and analysis of the markets for emerging growth company investment and finance. Our analysts and correspondents provide news coverage and research on public and private investment in pre-IPO and public reporting high-growth companies valued under $1 billion, via PIPEs, Reg A, Reg D, self-directed IPOs and other alternative offerings.

Follow Us

  • Growth Capitalist
  • REGISTER FOR TRIAL
  • SUBSCRIBE
  • MEMBER LOGIN
  • ARCHIVE
  • PRIVACY POLICY
  • MARKETNEXUS MEDIA

Search

Article Archive

© Copyright 2026, Growth Capitalist

Back to top ↑

Close
loading...